Ionis Pharmaceuticals Inc (IONS)
38.76
+0.37
(+0.96%)
USD |
NASDAQ |
Nov 01, 16:00
38.76
0.00 (0.00%)
After-Hours: 20:00
Ionis Pharmaceuticals Profit Margin (Quarterly): -29.42% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -29.42% |
| March 31, 2024 | -119.5% |
| December 31, 2023 | -2.85% |
| September 30, 2023 | -102.2% |
| June 30, 2023 | -45.27% |
| March 31, 2023 | -95.25% |
| December 31, 2022 | -34.52% |
| September 30, 2022 | -29.41% |
| June 30, 2022 | -78.58% |
| March 31, 2022 | -45.92% |
| December 31, 2021 | 51.05% |
| September 30, 2021 | -61.96% |
| June 30, 2021 | -64.31% |
| March 31, 2021 | -80.52% |
| December 31, 2020 | -122.1% |
| September 30, 2020 | -15.28% |
| June 30, 2020 | -17.61% |
| March 31, 2020 | -29.71% |
| December 31, 2019 | 34.11% |
| September 30, 2019 | 15.58% |
| June 30, 2019 | -0.53% |
| March 31, 2019 | 28.41% |
| December 31, 2018 | |
| September 30, 2018 | -3.14% |
| June 30, 2018 | -34.27% |
| Date | Value |
|---|---|
| March 31, 2018 | -0.98% |
| December 31, 2017 | -1.74% |
| September 30, 2017 | -2.21% |
| June 30, 2017 | -2.75% |
| March 31, 2017 | 7.74% |
| December 31, 2016 | 27.89% |
| September 30, 2016 | 6.63% |
| June 30, 2016 | -147.8% |
| March 31, 2016 | -170.6% |
| December 31, 2015 | -138.5% |
| September 30, 2015 | -72.83% |
| June 30, 2015 | 29.60% |
| March 31, 2015 | -26.71% |
| December 31, 2014 | 36.59% |
| September 30, 2014 | -60.54% |
| June 30, 2014 | -21.17% |
| March 31, 2014 | -111.1% |
| December 31, 2013 | -57.46% |
| September 30, 2013 | -104.2% |
| June 30, 2013 | -26.58% |
| March 31, 2013 | -3.86% |
| December 31, 2012 | -13.27% |
| September 30, 2012 | -324.4% |
| June 30, 2012 | -2.55% |
| March 31, 2012 | -103.3% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-122.1%
Minimum
Dec 2020
51.05%
Maximum
Dec 2021
-46.81%
Average
-45.27%
Median
Jun 2023
Profit Margin (Quarterly) Benchmarks
| Biogen Inc | 15.76% |
| Alnylam Pharmaceuticals Inc | -22.27% |
| Biomarin Pharmaceutical Inc | 14.22% |
| Rigel Pharmaceuticals Inc | -2.80% |
| Apellis Pharmaceuticals Inc | -18.86% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -108.2% |
| Return on Assets | -12.74% |
| Return on Invested Capital | -22.52% |
| Gross Profit Margin (Quarterly) | 98.15% |
| Operating Margin (Quarterly) | -29.34% |
| Return on Net Operating Assets | -108.8% |